phentolamine has been researched along with Sclerosis, Systemic in 1 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phlippoteau, C | 1 |
| Brenot, F | 1 |
| Blétry, O | 1 |
| Simmonneau, G | 1 |
| Duroux, P | 1 |
1 other study available for phentolamine and Sclerosis, Systemic
| Article | Year |
|---|---|
[Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Epoprostenol; Female; Humans; Hydralazine; Hypertension | 1990 |